5-(1,2,4-Triazol-1-ylmethyl)-3H-isobenzofuran-1-one derivatives, their preparation and use as aromatase inhibitors
申请人:GLAXO GROUP LIMITED
公开号:EP0574992A1
公开(公告)日:1993-12-22
This invention relates to heterocyclic compounds which are inhibitors of the enzyme aromatase, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine.
Particular compounds of the invention are compounds of formula (I)
wherein R¹ represents a cyano or nitro group;
R² represents hydrogen or one or more halogen atoms;
R³ represents a C₁₋₆alkyl group and R⁴ represents hydrogen or a C₁₋₆alkyl group or R³ and R⁴ together represent a C₃₋₆cycloalkyl group; and
R⁵ represents hydrogen or one or more halogen atoms or C₁₋₆alkoxy groups and pharmaceutically acceptable salts and solvates thereof.
5-(1,2,4-TRIAZOL-1-YLMETHYL)-3H-ISOBENZOFURAN-1-ONE DERIVATIVES, THEIR PREPARATION AND USE AS AROMATASE INHIBITORS
申请人:GLAXO GROUP LIMITED
公开号:EP0646114A1
公开(公告)日:1995-04-05
US5578630A
申请人:——
公开号:US5578630A
公开(公告)日:1996-11-26
[EN] 5-(1,2,4-TRIAZOL-1-YLMETHYL)-3H-ISOBENZOFURAN-1-ONE DERIVATIVES, THEIR PREPARATION AND USE AS AROMATASE INHIBITORS<br/>[FR] DERIVES DE 5-(1,2,4-TRIAZOL-1-YLMETHYL)-3H-ISOBENZOFURAN-1-ONE, LEUR PREPARATION ET LEUR UTILISATION COMME INHIBITEURS D'AROMATASE
申请人:GLAXO GROUP LIMITED
公开号:WO1993025548A1
公开(公告)日:1993-12-23
(EN) This invention relates to heterocyclic compounds which are inhibitors of the enzyme aromatase, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine. Particular compounds of the invention are compounds of formula (I) wherein R1 represents a cyano or nitro group; R2 represents hydrogen or one or more halogen atoms; R3 represents a C1-6alkyl group and R4 represents hydrogen or a C1-6alkyl group or R3 and R4 together represent a C3-6cycloalkyl group; and R5 represents hydrogen or one or more halogen atoms or C1-6alkoxy groups and pharmaceutically acceptable salts and solvates thereof.(FR) L'invention se rapporte à des composés hétérocycliques agissant comme inhibiteurs d'aromatase, à des procédés destinés à leur préparation, à des compositions pharmaceutiques les contenant ainsi qu'à leur utilisation en médecine. Les composés particuliers de l'invention répondent à la formule (I), dans laquelle R1 représente un groupe cyano ou nitro; R2 représente hydrogène ou un ou plusieurs atomes d'halogène; R3 représente un groupe C1-6alkyle et R4 représente hydrogène ou un groupe C1-6alkyle, ou R3 et R4 représentent ensemble un groupe C3-6cycloalkyle; et R5 représente hydrogène, ou un ou plusieurs atomes d'halogène, ou des groupes C1-6alcoxy. Des sels et des solvates pharmaceutiquement acceptables de ces composés sont également décrits.
Heterocyclic compounds which inhibit aromatase
申请人:Glaxo Group Limited
公开号:US05578630A1
公开(公告)日:1996-11-26
This invention relates to heterocyclic compounds which are inhibitors of the enzyme aromatase, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine. Particular compounds of the invention are compounds of formula (I) ##STR1## wherein R.sup.1 represents a cyano or nitro group; R.sup.2 represents hydrogen or one or more halogen atoms; R.sup.3 represents a C.sub.1-6 alkyl group and R.sup.4 represents hydrogen or a C.sub.1-6 alkyl group or R.sup.3 and R.sup.4 together represent a C.sub.3-6 cycloalkyl group; and R.sup.5 represents hydrogen or one or more halogen atoms or C.sub.1-6 alkoxy groups and pharmaceutically acceptable salts and solvates thereof.